Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.
Fiche publication
Date publication
décembre 2019
Journal
Autoimmunity reviews
Auteurs
Membres identifiés du Cancéropôle Est :
Dr D'AVENI-PINEY Maud
Tous les auteurs :
Roupie AL, de Boysson H, Thietart S, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Decaux O, d'Aveni M, Rossignol J, Galland J, Solary E, Willems L, Schleinitz N, Ades L, Dellal A, Samson M, Aouba A, Fenaux P, Fain O, Mekinian A,
Lien Pubmed
Résumé
Myelodysplastic syndromes (MDS) and MDS/myeloproliferative neoplasms (MDS/MPN) can be associated with giant cell arteritis (GCA). In this nationwide study by the "French Network of dysimmune disorders associated with hemopathies" (MINHEMON) the objective was to evaluate characteristics, treatment and outcome of GCA MDS-MDS/MPN.
Mots clés
Giant cell arteritis, Myelodysplastic syndrome, Outcome
Référence
Autoimmun Rev. 2019 Dec 12;:102446